KOVAI.NS
HoldFallen FavouriteKovai Medical Center and Hospital Limited · Healthcare · India · $696M · Avg Vol: $284K/d
Fallen Favourite: A good business, still expensive, and the price is falling.
Does StockRank work? Each month we publish how every decile did, whichever way it went. See the record →
ABOUT KOVAI MEDICAL CENTER AND HOSPITAL LIMITED
Read
Kovai Medical Center and Hospital Limited operates a multispecialty hospital and its satellite centers in India. It operates through two segments, Healthcare Services and Education Services.
FINANCIAL SUMMARY (INR)
| Year | 2023 | 2024 | 2025 | 2026 | CAGR | TTM |
|---|---|---|---|---|---|---|
| Revenue | 9.6B | 11.3B | 13.7B | 15.8B | 18.2% | 16.4B |
| EPS (INR) | 105.80 | 164.25 | 190.95 | 223.41 | 28.3% | 234.23 |
| Shares | 10.9M | 10.9M | 10.9M | 10.9M | 0.0% | 10.9M |
| Debt | 5.1B | 3.1B | 4.2B | 4.0B | -7.6% | 4.0B |
| Equity | 7.2B | 8.9B | 10.9B | 13.2B | 22.4% | — |
| Op CF | 2.6B | 3.4B | 3.3B | 3.6B | 11.2% | 3.7B |
| Inv CF | -1.3B | -1.4B | -3.3B | -2.3B | — | — |
| Fin CF | -857.0M | -2.4B | 620.9M | -583.7M | — | — |
SCORE BREAKDOWN
FUNDAMENTALS
SECTOR PEERS
Closest peers in Healthcare, ranked by industry match, size, and score similarity. Cross-listings of KOVAI.NS are excluded.
| Ticker | Company | Mkt Cap | StockRank | Signal |
|---|---|---|---|---|
| KOVAI.NS | Kovai Medical Center and Hospital Limited(you) | $696M | 47 | Hold |
| JLHL.NS | Jupiter Life Line Hospitals Limited | $915M | 51 | Hold |
| NEPHROPLUS.NS | Nephrocare Health Services Limited | $744M | 55 | Hold |
| HCG.NS | HealthCare Global Enterprises Limited | $1.1B | 57 | Hold |
| KMCSHIL.NS | KMC Speciality Hospitals (India) Limited | $268M | 48 | Hold |
| JSLL.NS | Jeena Sikho Lifecare Limited | $662M | 78 | Buy |
| YATHARTH.NS | Yatharth Hospital & Trauma Care Services Limited | $1.2B | 71 | Buy |
| RAINBOW.NS | Rainbow Children's Medicare Limited | $1.5B | 66 | Buy |
| KIMS.NS | Krishna Institute of Medical Sciences Limited | $3.5B | 45 | Hold |
| SHALBY.NS | Shalby Limited | $161M | 41 | Hold |
Peer medians: ROE 11.7% · P/E 43.0x · Gross margin 59.4%
Company Deep Dive
Business segments breakdown, earnings transcript analysis, management credibility scoring, competitive landscape, and scenario modelling.